404 DOSE REDUCTION OF PEGINTERFERON ALFA-2A (PEG) IN COMBINATION WITH RIBAVIRIN (RBV) IN CHRONIC HEPATITIS C (CHC) PATIENTS: IMPACT ON VIROLOGICAL RESPONSE UNDER REAL LIFE CONDITIONS

2011 ◽  
Vol 54 ◽  
pp. S162
Author(s):  
K. Boeker ◽  
S. Mauss ◽  
D. Hueppe ◽  
M. Schuchmann ◽  
W. Schiffelholz ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Dose Reduction ◽  
Chronic Hepatitis C ◽  
Virological Response ◽  
Real Life ◽  
Life Conditions ◽  
Peginterferon Alfa

M1794 Efficacy and Tolerability of Peginterferon Alfa-2a (40KD) (PEG) and Ribavirin (RBV) in Genotype 5 and 6 Patients with Chronic Hepatitis C Under Real Life Conditions

2009 ◽  
Vol 136 (5) ◽  
pp. A-839-A-840
Author(s):  
Dietrich Hueppe ◽  
Elmar Zehnter ◽  
Stefan Mauss ◽  
Stephan Kaiser ◽  
Andreas Schober ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real Life ◽  
Life Conditions ◽  
Genotype 5 ◽  
Peginterferon Alfa

W1010 Efficacy and Tolerability of Peginterferon Alfa-2a (40KD) and Ribavirin in Genotype 4 Patients with Chronic Hepatitis C (cHC) Under Real Life Conditions

2008 ◽  
Vol 134 (4) ◽  
pp. A-831
Author(s):  
Elmar Zehnter ◽  
Stefan Mauss ◽  
Dietrich Hueppe ◽  
Stephan Kaiser ◽  
Klaus Boeker ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real Life ◽  
Genotype 4 ◽  
Life Conditions ◽  
Peginterferon Alfa
Sign in / Sign up

Export Citation Format

Share Document